List of Schering patents

Patents where

Current Assignee

Name

‌

Schering

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7449488 Pyrazolopyrimidines as protein kinase inhibitors	Patent 7449488 was granted and assigned to Schering on November, 2008 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7449488	November 11, 2008
‌ US Patent 7166454 Codon-optimized β-secretase and methods of refolding and processing	Patent 7166454 was granted and assigned to Schering on January, 2007 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7166454	January 23, 2007
‌ US Patent 7285408 Crystalline form of an n231 mutant catalytic domain of ADAM33 and methods of use thereof	Patent 7285408 was granted and assigned to Schering on October, 2007 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7285408	October 23, 2007
‌ US Patent 7335758 Catalytic domain of ADAM33 and methods of use thereof	Patent 7335758 was granted and assigned to Schering on February, 2008 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7335758	February 26, 2008
‌ US Patent 7645762 Substituted pyrazolo[1,5-a] pyrimidines as protein kinase inhibitors	Patent 7645762 was granted and assigned to Schering on January, 2010 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7645762	January 12, 2010
‌ US Patent 7618649 Extended release oral dosage composition	Patent 7618649 was granted and assigned to Schering on November, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7618649	November 17, 2009
‌ US Patent 7601724 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors	Patent 7601724 was granted and assigned to Schering on October, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7601724	October 13, 2009
‌ US Patent 7247631 Pegylated interferon alfa-CCR5 antagonist combination HIV therapy	Patent 7247631 was granted and assigned to Schering on July, 2007 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7247631	July 24, 2007
‌ US Patent 7405223 Treating allergic and inflammatory conditions	Patent 7405223 was granted and assigned to Schering on July, 2008 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7405223	July 29, 2008
‌ US Patent 7482360 Fused tetracyclic mGluR1 antagonists as therapeutic agents	Patent 7482360 was granted and assigned to Schering on January, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7482360	January 27, 2009
‌ US Patent 7632920 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof	Patent 7632920 was granted and assigned to Schering on December, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7632920	December 15, 2009
‌ US Patent 7135555 Mammalian TNF-α convertases	Patent 7135555 was granted and assigned to Schering on November, 2006 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7135555	November 14, 2006
‌ US Patent 7485648 mGluR1 antagonists as therapeutic agents	Patent 7485648 was granted and assigned to Schering on February, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7485648	February 3, 2009
‌ US Patent 7776862 Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity	Patent 7776862 was granted and assigned to Schering on August, 2010 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7776862	August 17, 2010
‌ US Patent 7547523 Histamine receptor	Patent 7547523 was granted and assigned to Schering on June, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7547523	June 16, 2009
‌ US Patent 7157244 Adenosine receptor	Patent 7157244 was granted and assigned to Schering on January, 2007 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7157244	January 2, 2007
‌ US Patent 8148363 Heterocyclic compounds as factor IXA inhibitors	Patent 8148363 was granted and assigned to Schering on April, 2012 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	8148363	April 3, 2012
‌ US Patent 7563798 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors	Patent 7563798 was granted and assigned to Schering on July, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7563798	July 21, 2009
‌ US Patent 7138264 Modified tumor necrosis factor-alpha converting enzyme and methods of use thereof	Patent 7138264 was granted and assigned to Schering on November, 2006 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7138264	November 21, 2006
‌ US Patent 7529628 Methods for identifying modified tumor necrosis factor-alpha converting enzyme inhibitors	Patent 7529628 was granted and assigned to Schering on May, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7529628	May 5, 2009
‌ US Patent 7387794 Preparation of powder agglomerate	Patent 7387794 was granted and assigned to Schering on June, 2008 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7387794	June 17, 2008
‌ US Patent 7605155 Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors	Patent 7605155 was granted and assigned to Schering on October, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7605155	October 20, 2009
‌ US Patent 7498409 Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists	Patent 7498409 was granted and assigned to Schering on March, 2009 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7498409	March 3, 2009
‌ US Patent 7354921 Pyrazolotriazines as kinase inhibitors	Patent 7354921 was granted and assigned to Schering on April, 2008 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7354921	April 8, 2008
‌ US Patent 7166602 Pyrazolotriazines as kinase inhibitors	Patent 7166602 was granted and assigned to Schering on January, 2007 by the United States Patent and Trademark Office.	‌ Schering	United States Patent and Trademark Office	7166602	January 23, 2007

...

Results per page:

474 results

0 selected

474 results

0 selected